AI & Machine LearningEvolutionary Algorithms in Digital Healthcare
We specialise in developing technologies for the diagnosis and monitoring of Parkinson’s, Alzheimer’s and other neurodegenerative conditions. Our clinically-validated medical devices have been used in medical centres and clinical trials worldwide.
Introducing ClearSky MD
Who we are
ClearSky Medical Diagnostics began as a collaboration with specialists from Leeds General Infirmary, Heriot-Watt University and the University of York who provided clinical expertise and machine learning knowledge.
We’re led by Professor Stephen Smith, who has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s.
Monitoring side-effects of medication for Parkinson’s. LID-Monitor offers a safe, simple and unobtrusive way of monitoring dyskinesia in the home.
Differentiating between neurodegenerative conditions. Data gloves with positioning sensors are worn to monitor how people perform simple test-grasp tasks.
Confirming diagnosis of Parkinson’s disease. PD-Monitor assists specialists by measuring symptoms of Parkinson’s while patients undertake routine clinical tasks.
Objectively assessing visuo-spatial ability. Patients draw on a digitising tablet and their hesitations and differences in movements are measured and analysed by the evolutionary algorithms.
PD-Monitor could differentiate Parkinson’s from essential tremor without bradykinesia with high accuracy, sensitivity and specificity – according to a study.
Professor Smith highlighted the work of ClearSky in diagnosing and monitoring Parkinson’s at a UK–China university consortium in November.
ClearSky’s PD-Monitor has been used in a nationwide study to investigate whether statins are effective in slowing the progress of Parkinson’s.
We offer a range of consultancy services.
We have a number of clinical studies underway.
Get in touch